approval · primary record
TELISOTUZUMAB VEDOTIN-TLLV
FDA · BLA · 2025-05-14
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2025-05-14 |
| Brand | EMRELIS |
| Sponsor | ABBVIE INC |
| Route | SINGLE-DOSE |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T03:31:04.376Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:TELISOTUZUMAB VEDOTIN-TLLV:2025-05-14
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.